ChromaVision system improves HercepTest results
This article was originally published in Clinica
Executive Summary
ChromaVision Medical Systems' Automated Cellular Imaging System (ACIS) "improves the interpretive scoring ability of even an inexperienced pathologist to a level above that of an expert pathologist in manual immunohistochemical assessment of HER2 status", the San Juan Capistrano, California-based company says. The claim is based on the findings of a study that compared ACIS-assisted immunohistochemical evaluation of HER2 protein expression to manual immunohistochemical evaluation and evaluation by fluorescence in situ hybridisation (FISH).